PT83202B - Processo para a preparacao de compostos triciclicos aromaticos e de composicoes farmaceuticas que os contem - Google Patents

Processo para a preparacao de compostos triciclicos aromaticos e de composicoes farmaceuticas que os contem

Info

Publication number
PT83202B
PT83202B PT83202A PT8320286A PT83202B PT 83202 B PT83202 B PT 83202B PT 83202 A PT83202 A PT 83202A PT 8320286 A PT8320286 A PT 8320286A PT 83202 B PT83202 B PT 83202B
Authority
PT
Portugal
Prior art keywords
sub
sup
preparation
pharmaceutical compositions
compositions containing
Prior art date
Application number
PT83202A
Other languages
English (en)
Other versions
PT83202A (en
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of PT83202A publication Critical patent/PT83202A/pt
Publication of PT83202B publication Critical patent/PT83202B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C07D313/02—Seven-membered rings
    • C07D313/06—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D313/10—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D313/12—[b,e]-condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/38—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C07D313/02—Seven-membered rings
    • C07D313/06—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D313/10—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D313/14—[b,f]-condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/30—Ortho- or ortho- and peri-condensed systems containing three rings containing seven-membered rings
    • C07C2603/32—Dibenzocycloheptenes; Hydrogenated dibenzocycloheptenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PT83202A 1985-08-17 1986-08-14 Processo para a preparacao de compostos triciclicos aromaticos e de composicoes farmaceuticas que os contem PT83202B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858520662A GB8520662D0 (en) 1985-08-17 1985-08-17 Tricyclic aromatic compounds

Publications (2)

Publication Number Publication Date
PT83202A PT83202A (en) 1986-09-01
PT83202B true PT83202B (pt) 1989-03-30

Family

ID=10583945

Family Applications (1)

Application Number Title Priority Date Filing Date
PT83202A PT83202B (pt) 1985-08-17 1986-08-14 Processo para a preparacao de compostos triciclicos aromaticos e de composicoes farmaceuticas que os contem

Country Status (13)

Country Link
US (1) US4871865A (pt)
EP (3) EP0214779B1 (pt)
JP (2) JPH0739346B2 (pt)
AT (3) ATE97401T1 (pt)
DE (3) DE3670290D1 (pt)
ES (1) ES2001519A6 (pt)
GB (1) GB8520662D0 (pt)
GR (1) GR862137B (pt)
HK (1) HK97593A (pt)
HU (1) HU201520B (pt)
IL (1) IL79729A (pt)
PT (1) PT83202B (pt)
SG (1) SG38393G (pt)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6310784A (ja) * 1986-03-03 1988-01-18 Kyowa Hakko Kogyo Co Ltd 抗アレルギー剤
JPH07116174B2 (ja) * 1987-02-27 1995-12-13 協和醗酵工業株式会社 ジベンズ〔ｂ，ｅ〕オキセピン誘導体
AU605501B2 (en) * 1987-08-25 1991-01-17 Kyowa Hakko Kirin Co., Ltd. Dibenz(b,e)oxepin derivative and antiallergic agent
US4882351A (en) * 1987-10-14 1989-11-21 Roussel Uclaf Tricyclic compounds
US4994463A (en) * 1987-12-14 1991-02-19 Kyowa Hakko Kogyo Co., Ltd. Tricyclic thromboxane A2 antagonists
US4999363A (en) * 1988-06-09 1991-03-12 Kyowa Hakko Kogyo Co., Ltd. Tricyclic compounds
US5242931A (en) * 1988-06-09 1993-09-07 Kyowa Hakko Kogyo Co., Ltd. Tricyclic compounds as TXA2 antagonists
GB8914061D0 (en) * 1989-06-19 1989-08-09 Wellcome Found Agents for potentiating the effects of antitumour agents and combating multiple drug resistance
US5208238A (en) * 1989-06-19 1993-05-04 Burroughs Wellcome Company Agents for potentiating the effects of antitumor agents and combating multiple drug resistance
NZ234110A (en) * 1989-06-19 1993-01-27 Wellcome Found Dibenzoazepine, -oxepine and -cycloheptane substituted alkylidene amines; pharmaceutical compositions containing such compounds or various other aryl substituted amines
GB8914040D0 (en) * 1989-06-19 1989-08-09 Wellcome Found Agents for potentiating the effects of antitumour agents and combating multiple drug resistance
GB8914060D0 (en) * 1989-06-19 1989-08-09 Wellcome Found Agents for potentiating the effects of antitumour agents and combating multiple drug resistance
CA2073078A1 (en) * 1991-07-09 1993-01-10 Tatsuya Hashinaga Semiconductor device testing apparatus
US5641805A (en) * 1995-06-06 1997-06-24 Alcon Laboratories, Inc. Topical ophthalmic formulations for treating allergic eye diseases
US5899727A (en) 1996-05-02 1999-05-04 Advanced Micro Devices, Inc. Method of making a semiconductor isolation region bounded by a trench and covered with an oxide to improve planarization
DE19848200A1 (de) * 1998-10-20 2000-04-27 Basf Ag Verfahren zur Trocknung von Phenoxymethylbenzoesäuren
US6174914B1 (en) 1999-06-15 2001-01-16 Alcon Laboratories, Inc. Method of inhibiting cytokine release from human ocular cells
EP1187617B1 (en) 1999-06-18 2004-03-03 Alcon Manufacturing Ltd. Method for selecting the concentration of an amphipathic antihistamine drug by determining the drug's surface activity rating
US6174878B1 (en) 1999-08-31 2001-01-16 Alcon Laboratories, Inc. Topical use of kappa opioid agonists to treat otic pain
US20040097486A1 (en) * 1999-11-18 2004-05-20 Yanni John M. Use of an H1 antagonist and a safe steroid to treat eye conditions
DE60109742T2 (de) 2000-01-25 2005-08-18 Alcon Inc. Antiallergische ophthalmische zubereitungen, geeignet zur anwendung mit kontaktlinsen
WO2001090060A1 (en) 2000-05-19 2001-11-29 Alcon Universal Ltd. Disulfide derivatives useful for treating allergic diseases
TR200402299T4 (tr) 2000-05-19 2004-12-21 Alcon, Inc. Alerjik hastalıkların tedavisi için anilin disülfit türevleri
CA2407767A1 (en) 2000-05-19 2001-11-29 Alcon, Inc. Compositions containing a benzamide disulfide derivative for treating allergic diseases
US7977376B2 (en) * 2001-06-27 2011-07-12 Novartis Ag Olopatadine formulations for topical nasal administration
TWI231759B (en) * 2001-06-27 2005-05-01 Alcon Inc Olopatadine formulations for topical administration
ES2258175T3 (es) * 2001-12-05 2006-08-16 Alcon, Inc. Utilizacion de un antagonista de h1 y remixolona como esteroide inofensivo para el tratamiento de la rinitis.
US20050209312A1 (en) * 2004-03-19 2005-09-22 Bausch & Lomb Incorporated Carboxylic acid derivatives of doxepin formulations preserved with low-irritation preservative
CA2569519A1 (en) * 2004-06-28 2006-01-12 Alcon, Inc. Topical formulations for treating allergic diseases
ES2253996B1 (es) * 2004-07-28 2007-08-16 Urquima, S.A. Procedimiento para la preparacion del acido 11-((z)-3-(dimetilamino)propiliden)-6,11-dihidrodibenz(b,e)oxepinacetico.
WO2006057769A2 (en) * 2004-11-24 2006-06-01 Alcon, Inc. Method of delivering nasal spray
CA2634665A1 (en) 2005-12-22 2007-10-25 Medichem, S.A. Crystalline polymorphic forms of olopatadine hydrochloride and processes for their preparation
US7950020B2 (en) * 2006-03-16 2011-05-24 Ntt Docomo, Inc. Secure operating system switching
US7687646B2 (en) * 2006-03-28 2010-03-30 Azad Pharmaceutical Ingredients, Ag Polymorphic forms of olopatadine hydrochloride and methods for producing olopatadine and salts thereof
US8445437B2 (en) * 2006-07-27 2013-05-21 The Brigham And Women's Hospital, Inc. Treatment and prevention of cardiovascular disease using mast cell stabilizers
US20080139531A1 (en) * 2006-12-04 2008-06-12 Alcon Manufacturing Ltd. Use of connective tissue mast cell stabilizers to facilitate ocular surface re-epithelization and wound repair
SI2114367T1 (sl) 2007-02-07 2016-01-29 Novartis Ag Formulacije olopatadina za topično nazalno dajanje
CN101605773B (zh) * 2007-02-16 2014-07-23 住友化学株式会社 二苯并氧杂*化合物的制造方法
AR066016A1 (es) * 2007-04-11 2009-07-15 Alcon Res Ltd Uso de un inhibidor del tnf alfa junto con una antihistamina para tratar la rinitis alergica y la conjuntivitis alergica
US20090182035A1 (en) * 2007-04-11 2009-07-16 Alcon Research, Ltd. Use of a combination of olopatadine and cilomilast to treat non-infectious rhinitis and allergic conjunctivitis
EP2205243A4 (en) 2007-09-28 2012-06-13 Brigham & Womens Hospital STABILIZERS OF MAST CELLS IN THE TREATMENT OF OBESITY
CA2719068C (en) * 2008-03-20 2016-10-11 Lek Pharmaceuticals D.D. Catalyzed carbonylation in the synthesis of angiotensin ii antagonists
US10517839B2 (en) * 2008-06-09 2019-12-31 Cornell University Mast cell inhibition in diseases of the retina and vitreous
ES2433715T3 (es) * 2008-07-16 2013-12-12 Crystal Pharma, S.A.U. Procedimiento de obtención de olopatadina e intermedios
US8835655B2 (en) * 2009-02-05 2014-09-16 Zach System S.P.A Process for preparing olopatadine and/or a pharmaceutically acceptable salt thereof
IT1397503B1 (it) 2009-04-21 2013-01-16 F S I Fabbrica Italiana Sint Processo per la preparazione di olopatadina
PT2453872E (pt) * 2009-07-17 2013-10-30 Alcon Res Ltd Regime de pulverização nasal de olopatadina para crianças
WO2011027322A1 (en) 2009-09-03 2011-03-10 Ranbaxy Laboratories Limited Extended release dosage form containing olopatadine for oral administration
RU2012117141A (ru) 2009-10-01 2013-11-10 Алькон Рисерч, Лтд. Композиции олопатадина и способы их применения
TWI544922B (zh) 2011-05-19 2016-08-11 愛爾康研究有限公司 高濃度歐羅派特錠（ｏｌｏｐａｔａｄｉｎｅ）眼用組成物
US9867800B2 (en) 2012-08-10 2018-01-16 Hallstar Innovations Corp. Method of quenching singlet and triplet excited states of pigments, such as porphyrin compounds, particularly protoporphyrin IX, with conjugated fused tricyclic compounds have electron withdrawing groups, to reduce generation of reactive oxygen species, particularly singlet oxygen
US9145383B2 (en) 2012-08-10 2015-09-29 Hallstar Innovations Corp. Compositions, apparatus, systems, and methods for resolving electronic excited states
PL3043773T3 (pl) 2013-09-13 2021-12-13 Glenmark Specialty S.A. Stabilna stała dawka kompozycji farmaceutycznej zawierającej mometazon i olopatadynę do podania donosowego
US9937189B2 (en) 2013-09-13 2018-04-10 Glenmark Specialty S.A. Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine
US9370483B2 (en) 2013-09-13 2016-06-21 Glenmark Specialty S.A. Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine
US10548907B2 (en) 2013-10-04 2020-02-04 Glenmark Specialty S.A. Treatment of allergic rhinitis using a combination of mometasone and olopatadine
US10758550B2 (en) 2013-10-04 2020-09-01 Glenmark Specialty S.A. Treatment of allergic rhinitis using a combination of mometasone and olopatadine
JP6419195B2 (ja) 2013-10-04 2018-11-07 グレンマーク・スペシャルティー・エスエー モメタゾンおよびオロパタジンの組み合わせを使用するアレルギー性鼻炎の治療
US10016443B2 (en) 2013-10-04 2018-07-10 Glenmark Specialty S.A. Treatment of allergic rhinitis using a combination of mometasone and olopatadine
US10653661B2 (en) 2013-10-04 2020-05-19 Glenmark Specialty S.A. Treatment of allergic rhinitis using a combination of mometasone and olopatadine
US20150224077A1 (en) 2014-02-10 2015-08-13 Patara Pharma, LLC Methods for the Treatment of Systemic Disorders Treatable with Mast Cell Stabilizers, including Mast Cell Related Disorders
EP3725311A1 (en) 2014-02-10 2020-10-21 Respivant Sciences GmbH Methods for the treatment of lung diseases with mast cell stabilizers
US11679210B2 (en) 2014-10-03 2023-06-20 Glenmark Specialty S.A. Dispensing device and pharmaceutical composition for the treatment of rhinitis
US10238625B2 (en) 2015-08-07 2019-03-26 Respivant Sciences Gmbh Methods for the treatment of mast cell related disorders with mast cell stabilizers
US10265296B2 (en) 2015-08-07 2019-04-23 Respivant Sciences Gmbh Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders
JP2019528320A (ja) 2016-08-31 2019-10-10 レシュピファント サイエンシス ゲゼルシャフト ミット ベシュレンクター ハフトゥングＲｅｓｐｉｖａｎｔ Ｓｃｉｅｎｃｅｓ Ｇｍｂｈ 特発性肺線維症による慢性咳の治療のためのクロモリン組成物
EP3522983A4 (en) 2016-10-07 2020-06-03 Respivant Sciences GmbH CROMOLYNE-BASED COMPOSITIONS FOR THE TREATMENT OF PULMONARY FIBROSIS
MX2020008741A (es) 2018-02-23 2020-09-28 Glenmark Specialty Sa Tratamiento de la rinitis alergica en sujetos pediatricos con una combinacion de mometasona y olopatadina.
WO2021094296A1 (en) 2019-11-12 2021-05-20 INSERM (Institut National de la Santé et de la Recherche Médicale) Use of mast cell stabilizer for the treatment of heart failure with preserved ejection fraction

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL58901C (pt) * 1957-02-07 1947-02-15
DE1232161B (de) * 1961-10-07 1967-01-12 Boehringer & Soehne Gmbh Verfahren zur Herstellung von basisch substituierten Dibenzo-oxepinen und deren Salzen
BE641498A (pt) * 1962-03-13
US3401192A (en) * 1962-07-17 1968-09-10 Merck & Co Inc Esters of 5h-dibenzo [a, d] cycloheptene
US3420851A (en) * 1962-12-19 1969-01-07 Pfizer & Co C Novel dibenzoxepines
US3509175A (en) * 1963-10-14 1970-04-28 Pfizer & Co C Recovery of pure cis 11-(3-dimethylaminopropylidene) - 6,11 - dihydrodibenz(b,e)oxepine from admixture with its trans isomer
GB1076612A (en) * 1964-07-24 1967-07-19 Merck & Co Inc Dibenzocycloheptene derivatives
FR2138257B1 (pt) * 1971-05-21 1974-08-23 Roussel Uclaf
OA04603A (fr) * 1973-03-02 1980-06-30 Rhone Poulenc Sa Nouveaux dérivés du dibenzo [a,d] cycloheptene, leurs sels et leur préparation.
US3966820A (en) * 1974-07-05 1976-06-29 Syntex (U.S.A.) Inc. 2-Substituted-5-oxo-5H-dibenzo-[A,D]cycloheptenes, the esters and ethers thereof, having pharmaceutical activity, and methods and compositions for the use thereof
JPS5139683A (ja) * 1974-10-02 1976-04-02 Dai Ichi Kogyo Seiyaku Co Ltd Jibenzookisebinjudotaino seizoho
JPS5516590A (en) * 1978-07-21 1980-02-05 Nec Corp Television relay broadcasting equipment
US4282365A (en) * 1978-11-24 1981-08-04 Merck & Co., Inc. Dibenz[b,e]oxepin compounds
US4307245A (en) * 1978-12-29 1981-12-22 Syva Company Amitriptyline conjugates to antigenic proteins and enzymes
US4223013A (en) * 1978-12-29 1980-09-16 Syva Company Amitriptyline conjugates to antigenic proteins and enzymes
JPS56156273A (en) * 1980-03-31 1981-12-02 Dainippon Pharmaceut Co Ltd Acetic derivative
US4412999A (en) * 1982-04-14 1983-11-01 Merck & Co., Inc. Anti-emetic esters of cyproheptadine-3-carboxylic acid and structurally related compounds
JPS6028972A (ja) * 1983-06-29 1985-02-14 Kyowa Hakko Kogyo Co Ltd ジベンゾ［ｂ，ｅ］オキセピン誘導体

Also Published As

Publication number Publication date
DE3650357D1 (de) 1995-08-31
ATE97401T1 (de) 1993-12-15
EP0351887A1 (en) 1990-01-24
ATE125535T1 (de) 1995-08-15
JPH0739346B2 (ja) 1995-05-01
GB8520662D0 (en) 1985-09-25
IL79729A0 (en) 1986-11-30
US4871865A (en) 1989-10-03
EP0214779A1 (en) 1987-03-18
HUT41761A (en) 1987-05-28
HU201520B (en) 1990-11-28
HK97593A (en) 1993-09-24
DE3650357T2 (de) 1996-01-04
ATE51867T1 (de) 1990-04-15
EP0214779B1 (en) 1990-04-11
GR862137B (en) 1986-12-30
DE3689311D1 (de) 1993-12-23
SG38393G (en) 1993-06-11
PT83202A (en) 1986-09-01
JPS6245557A (ja) 1987-02-27
EP0316022A2 (en) 1989-05-17
ES2001519A6 (es) 1988-06-01
JP2556821B2 (ja) 1996-11-27
JPH07165749A (ja) 1995-06-27
DE3689311T2 (de) 1994-03-10
DE3670290D1 (de) 1990-05-17
IL79729A (en) 1990-11-05
EP0351887B1 (en) 1995-07-26
EP0316022A3 (en) 1989-10-11
EP0316022B1 (en) 1993-11-18

Similar Documents

Publication Publication Date Title
PT83202B (pt) Processo para a preparacao de compostos triciclicos aromaticos e de composicoes farmaceuticas que os contem
FI891176A0 (fi) Peptidfoereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar.
PT91121A (pt) Processo para a preparacao de derivados da quinolina e de composicoes farmaceuticas que os contem
ES8500232A1 (es) Un metodo para preparar compuestos de piridilo
PT89788A (pt) Processo de preparacao de derivados da quinolina substituidas e de composicoes farmaceuticas que os contem
PT82897B (pt) Processo de preparacao de derivados de di-hidropiridazinona
ATE48001T1 (de) Cephemverbindungen, verfahren zu ihrer herstellung und ihre pharmazeutischen praeparate.
PT921119E (pt) Novos derivados de pirrol, processo para a sua preparacao e as composicoes farmaceuticas que os contem
AU539986B2 (en) Nitroso-urea compounds + alkylene amine derivatives of ureas
ES556048A0 (es) Un procedimiento para la preparacion de un derivado de tiazolidina.
ES8800206A1 (es) Un procedimiento para preparar derivados de 2-aminopirimidinona
ES8600762A1 (es) Un procedimiento para la preparacion de nuevos compuestos de beta-lactama.